CD274 and neoplasm: Indeed, the determination of tumoral PD-L1 expression by immunohistochemistry (IHC), as well as the quantification of lymphocytes and tumor-infiltrating lymphocytes (TILs) are being questioned as markers of predictive value of response7,11.